Research Analysts’ Updated EPS Estimates for January 22nd (AGEN, ALT, AMZN, ANIX, ASM, ATRA, BCYC, BIRK, CAN, CMG)

Research Analysts’ updated eps estimates for Wednesday, January 22nd:

Agenus (NASDAQ:AGEN) had its neutral rating reiterated by analysts at HC Wainwright.

Altimmune (NASDAQ:ALT) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $12.00 price target on the stock.

Amazon.com (NASDAQ:AMZN) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $270.00 price target on the stock.

Anixa Biosciences (NASDAQ:ANIX) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 price target on the stock.

Avino Silver & Gold Mines (NYSE:ASM) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $1.90 price target on the stock, up from their previous price target of $1.80.

Avino Silver & Gold Mines (NYSE:ASM) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $1.90 target price on the stock, up from their previous target price of $1.80.

Atara Biotherapeutics (NASDAQ:ATRA) had its neutral rating reaffirmed by analysts at HC Wainwright.

Bicycle Therapeutics (NASDAQ:BCYC) had its equal weight rating reiterated by analysts at Stephens. They currently have a $15.00 target price on the stock.

Birkenstock (NYSE:BIRK) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $70.00 price target on the stock.

Canaan (NASDAQ:CAN) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $3.00 target price on the stock.

Chipotle Mexican Grill (NYSE:CMG) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $69.00 price target on the stock.

Cocrystal Pharma (NASDAQ:COCP) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $7.00 price target on the stock.

Camden Property Trust (NYSE:CPT) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $121.00 target price on the stock.

CorMedix (NASDAQ:CRMD) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $15.00 target price on the stock.

Datadog (NASDAQ:DDOG) had its neutral rating reaffirmed by analysts at Guggenheim.

D.R. Horton (NYSE:DHI) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $210.00 price target on the stock.

D.R. Horton (NYSE:DHI) had its underperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $125.00 target price on the stock.

Walt Disney (NYSE:DIS) had its buy rating reissued by analysts at Citigroup Inc.. The firm currently has a $125.00 target price on the stock.

Dynatrace (NYSE:DT) had its neutral rating reaffirmed by analysts at Guggenheim.

Estée Lauder Companies (NYSE:EL) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $81.00 price target on the stock.

Evolus (NASDAQ:EOLS) had its buy rating reissued by analysts at HC Wainwright. They currently have a $27.00 price target on the stock.

Exelixis (NASDAQ:EXEL) had its buy rating reiterated by analysts at Guggenheim.

Fidelity National Information Services (NYSE:FIS) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $104.00 price target on the stock.

Fifth Third Bancorp (NASDAQ:FITB) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $47.00 target price on the stock.

Fifth Third Bancorp (NASDAQ:FITB) had its overweight rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $53.00 price target on the stock, down from their previous price target of $54.00.

First Solar (NASDAQ:FSLR) had its buy rating reissued by analysts at Guggenheim. The firm currently has a $335.00 price target on the stock.

FTAI Aviation (NYSE:FTAI) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $160.00 target price on the stock.

General Electric (NYSE:GE) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $200.00 target price on the stock.

Guardant Health (NASDAQ:GH) had its buy rating reiterated by analysts at Guggenheim.

Garrett Motion (NYSE:GTX) had its buy rating reissued by analysts at BWS Financial. BWS Financial currently has a $12.00 price target on the stock.

Hancock Whitney (NASDAQ:HWC) had its strong-buy rating reaffirmed by analysts at Raymond James. They currently have a $72.00 target price on the stock, up from their previous target price of $64.00.

Hancock Whitney (NASDAQ:HWC) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $74.00 target price on the stock, up from their previous target price of $68.00.

Interactive Brokers Group (NASDAQ:IBKR) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $210.00 target price on the stock, up from their previous target price of $200.00.

Inhibrx (NASDAQ:INBX) had its market perform rating reaffirmed by analysts at JMP Securities.

Century Therapeutics (NASDAQ:IPSC) had its buy rating reiterated by analysts at Guggenheim.

Century Therapeutics (NASDAQ:IPSC) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $5.00 target price on the stock.

Intra-Cellular Therapies (NASDAQ:ITCI) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $132.00 price target on the stock, up from their previous price target of $108.00.

Kairos Pharma (NYSEAMERICAN:KAPA) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $9.00 price target on the stock.

KeyCorp (NYSE:KEY) had its overweight rating reaffirmed by analysts at Stephens. They currently have a $20.00 price target on the stock.

KeyCorp (NYSE:KEY) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $18.00 target price on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $26.00 price target on the stock.

Masimo (NASDAQ:MASI) had its hold rating reaffirmed by analysts at Needham & Company LLC.

3M (NYSE:MMM) had its underperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $96.00 target price on the stock.

Monster Beverage (NASDAQ:MNST) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $59.00 price target on the stock.

Murphy Oil (NYSE:MUR) had its underweight rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $37.00 price target on the stock.

Netflix (NASDAQ:NFLX) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $1,100.00 target price on the stock, up from their previous target price of $950.00.

Netflix (NASDAQ:NFLX) had its outperform rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $1,175.00 price target on the stock, up from their previous price target of $1,000.00.

ServiceNow (NYSE:NOW) had its sell rating reaffirmed by analysts at Guggenheim. They currently have a $716.00 target price on the stock.

Nexstar Media Group (NASDAQ:NXST) had its buy rating reiterated by analysts at Guggenheim.

Old National Bancorp (NASDAQ:ONB) had its strong-buy rating reaffirmed by analysts at Raymond James. The firm currently has a $29.00 target price on the stock, up from their previous target price of $28.00.

Old National Bancorp (NASDAQ:ONB) had its overweight rating reaffirmed by analysts at Stephens. They currently have a $27.00 price target on the stock.

Old National Bancorp (NASDAQ:ONB) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $26.00 price target on the stock, up from their previous price target of $24.00.

Oracle (NYSE:ORCL) had its market outperform rating reaffirmed by analysts at JMP Securities. The firm currently has a $205.00 target price on the stock.

Pineapple Financial (NYSEAMERICAN:PAPL) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $5.00 target price on the stock.

Peoples Bancorp (NASDAQ:PEBO) had its equal weight rating reiterated by analysts at Stephens. They currently have a $37.50 target price on the stock.

Pinnacle Financial Partners (NASDAQ:PNFP) had its overweight rating reissued by analysts at Stephens. They currently have a $142.00 price target on the stock.

Paycor HCM (NASDAQ:PYCR) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $22.50 price target on the stock, up from their previous price target of $21.00.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $118.00 target price on the stock.

RadNet (NASDAQ:RDNT) had its buy rating reissued by analysts at Truist Financial Co.. The firm currently has a $88.00 target price on the stock, down from their previous target price of $94.00.

Rigel Pharmaceuticals (NASDAQ:RIGL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $57.00 target price on the stock.

Charles Schwab (NYSE:SCHW) had its buy rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $90.00 target price on the stock, up from their previous target price of $86.00.

Super Group (NYSE:SGHC) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $9.00 target price on the stock.

Shopify (NYSE:SHOP) (TSE:SHOP) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $130.00 price target on the stock.

Sanara MedTech (NASDAQ:SMTI) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $44.00 price target on the stock.

State Street (NYSE:STT) had its hold rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a $103.00 target price on the stock, down from their previous target price of $104.00.

Seagate Technology (NASDAQ:STX) had its outperform rating reaffirmed by analysts at Northland Securities. Northland Securities currently has a $160.00 price target on the stock, up from their previous price target of $144.00.

Seagate Technology (NASDAQ:STX) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $120.00 target price on the stock.

VF (NYSE:VFC) had its market perform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $21.00 price target on the stock.